MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma

MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma

Abstract Background Non-coding microRNAs (miRNAs) play critical roles in tumor progression and hold great promise as therapeutic agents for multiple cancers. MicroRNA 29a (miR-29a) is a tumor suppressor miRNA that inhibits cancer cell growth and tumor progression in non-small cell lung cancer. Carci...

Full description

Bibliographic Details
Main Authors:	Seung-Myoung Son, Jieun Yun, Dong-Wook Kim, Young-Suk Jung, Sang-Bae Han, Yong Hee Lee, Hye Sook Han, Chang Gok Woo, Ho-Chang Lee, Ok-Jun Lee
Format:	Article
Language:	English
Published:	BMC 2023-09-01
Series:	BMC Cancer
Subjects:	miR-29a Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) pH low insertion peptide (pHLIP) Lung adenocarcinoma Tumor microenvironment
Online Access:	https://doi.org/10.1186/s12885-023-11352-w

Similar Items

The pHLIP system as a vehicle for microRNAs in the kidney
by: Verónica Miguel, et al.
Published: (2020-09-01)

Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding
by: Yana K. Reshetnyak, et al.
Published: (2020-04-01)

pH Low Insertion Peptide-Modified Programmed Cell Death-Ligand 1 Potently Suppresses T-Cell Activation Under Acidic Condition
by: Ying Sun, et al.
Published: (2021-12-01)

Decoration of Nanovesicles with pH (Low) Insertion Peptide (pHLIP) for Targeted Delivery
by: Federica Rinaldi, et al.
Published: (2018-12-01)

pHLIP-fused PD-L1 engages avelumab to elicit NK cytotoxicity under acidic conditions
by: Junjuan Feng, et al.
Published: (2024-05-01)

Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy
by: Guo-Bin Ding, et al.
Published: (2022-12-01)

Targeting the Hypoxic and Acidic Tumor Microenvironment with pH-Sensitive Peptides
by: Nayanthara U. Dharmaratne, et al.
Published: (2021-03-01)

Binding of <italic toggle="yes">Candida albicans</italic> to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
by: Esther Klaile, et al.
Published: (2017-05-01)

Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment
by: Yuehua Chen, et al.
Published: (2022-04-01)

CEACAM6’s Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6’s Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA
by: Benediktas Kurlinkus, et al.
Published: (2021-06-01)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
by: Xueying Wang, et al.
Published: (2023-02-01)

CEACAM6 expression and function in tumor biology: a comprehensive review
by: Dong Zhao, et al.
Published: (2024-05-01)

CEACAM expression in an in-vitro prostatitis model
by: Irina Kube-Golovin, et al.
Published: (2023-08-01)

CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA‐146a and microRNA‐26a
by: He Du, et al.
Published: (2020-09-01)

Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer <it>via</it> suppression of apoptosis
by: Cameron Sarina, et al.
Published: (2012-09-01)

Multiplexed Imaging Reveals the Spatial Relationship of the Extracellular Acidity-Targeting pHLIP with Necrosis, Hypoxia, and the Integrin-Targeting cRGD Peptide
by: Zhao-Hui Jin, et al.
Published: (2022-11-01)

Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas
by: Eun Young Kim, et al.
Published: (2022-06-01)

Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker [version 2; peer review: 1 approved, 2 approved with reservations]
by: Darawan Rinchai, et al.
Published: (2024-04-01)

CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes
by: Zhifang Zhang, et al.
Published: (2019-01-01)

Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides
by: Yana K. Reshetnyak, et al.
Published: (2024-03-01)

CEACAM5 exacerbates asthma by inducing ferroptosis and autophagy in airway epithelial cells through the JAK/STAT6-dependent pathway
by: Si Liu, et al.
Published: (2025-12-01)

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
by: Kristen P. Zeligs, et al.
Published: (2020-06-01)

Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma
by: Jinge Xu, et al.
Published: (2018-02-01)

Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer
by: Hu X, et al.
Published: (2019-01-01)

Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
by: Chamutal Gur, et al.
Published: (2019-06-01)

Norepinephrine affects the interaction of adherent-invasive Escherichia coli with intestinal epithelial cells
by: Sobieszczańska Beata, et al.
Published: (2021-12-01)

Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 Promotes Carcinogenesis of Gastric Cancer and Anti-CEACAM6 Fluorescent Probe Can Diagnose the Precancerous Lesions
by: Fangmei An, et al.
Published: (2021-06-01)

High-yield production and purification of the fusion pH-responsive peptide GST-pHLIP in Escherichia coli BL21
by: Oscar Cienfuegos-Jiménez, et al.
Published: (2022-12-01)

Migration and invasion of NSCLC suppressed by the downregulation of Src/focal adhesion kinase using single, double and tetra domain anti- CEACAM6 antibodies
by: Shang-Jung Wu, et al.
Published: (2021-07-01)

An investigation into the role of inherited CEACAM gene family variants and colorectal cancer risk
by: Anna L. W. Huskey, et al.
Published: (2022-02-01)

Osteopontin’s colocalization with the adhesion molecule CEACAM5 in cytoplasm of carcinoma of tongue and its correlation with the invasion of that diease
by: Zhang Fan, et al.
Published: (2012-06-01)

Expression Of TIM-3 And CEACAM-1 In Bladder Urothelial Carcinoma ( Immunohistochmical And Histopathological Study )
by: Abla Sayed Mahmoud, et al.
Published: (2021-06-01)

The expression and modulation of CEACAM1 and tumor cell transformation
by: Valentina Fiori, et al.
Published: (2012-06-01)

CEACAM5 is correlated with Angio/Lymphangiogenesis of Prostatic Lesions
by: Yan Jie-ke, et al.
Published: (2014-04-01)

Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody
by: Anja Seckinger, et al.
Published: (2024-04-01)

Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis
by: Haruki Matsumoto, et al.
Published: (2022-12-01)

Efficacy of bivalent CEACAM6/4-1BBL genetic vaccine combined with anti-PD1 antibody in MC38 tumor model of mice
by: Yuzhen Li, et al.
Published: (2022-10-01)

CEACAM7 polymorphisms predict genetic predisposition to mortality in post-surgical septic shock patients
by: Felipe Pérez-García, et al.
Published: (2022-06-01)

Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects
by: Enea Ferlizza, et al.
Published: (2020-07-01)

Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA
by: Zhou Jinfeng, et al.
Published: (2011-12-01)